Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Virtual Clinical Trials: Perspectives in Dermatology

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Th17 Inhibitors in Active Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ciclosporin

    Publikation: Bog/antologi/afhandling/rapportRapportRådgivning

  2. Factors associated with citation of original articles in 5 high-impact-factor dermatology journals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Patients with a familial predisposition to hidradenitis suppurativa have a distinct clinical phenotype

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Online Patient Recruitment in Clinical Trials: Systematic Review and Meta-Analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

BACKGROUND: To date, there are no nationwide studies of the social and economic burden of psoriasis to patients in Denmark. Incentives for health care management based on patient-related outcomes and value (IMPROVE) in psoriasis and psoriatic arthritis is a project aimed at assisting movement from activity-based to outcome-based health care management. One of the key objectives in IMPROVE is to describe the disease-associated socioeconomic burden of psoriasis.

METHODS: A case-matched study of the impact of psoriasis on patients' income, employment and health care costs in Denmark was performed. The IMPROVE study was a retrospective analysis of patients with a hospital diagnosis of psoriasis identified from the Danish National Patient Registry (NPR). In total, 13,025 psoriasis patients and 25,629 matched controls were identified from the NPR. Data from psoriasis patients and matched controls were compared for social and economic factors including income, employment, health care costs and risk of comorbidities.

RESULTS: Psoriasis was associated with increased health care costs (mean annual costs +116% compared to control, p < 0.001), peaking in the year of referral to hospital for psoriasis and sustained thereafter. Both direct and indirect costs were significantly higher for patients with psoriasis than controls (p < 0.001). In the years before and immediately following hospital diagnosis, the rates of employment were lower in psoriasis patients than controls. Comorbidities, including cardiovascular (odds ratio 1.93 [95% CI 1.77-2.09]) and psychiatric conditions (odds ratio 2.61 [95% CI 2.30-2.97]), were more prevalent in patients with psoriasis than controls.

CONCLUSION: In Denmark, psoriasis has a significant impact on health care costs, income and employment, and is associated with a range of comorbidities.

OriginalsprogEngelsk
TidsskriftDermatology
Vol/bind235
Udgave nummer5
Sider (fra-til)372-379
Antal sider8
ISSN1018-8665
DOI
StatusUdgivet - 1 aug. 2019

Bibliografisk note

© 2019 S. Karger AG, Basel.

ID: 58311772